Product Information
LURASIDONE HCL 120 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.4867 per EA under NDC 65862095730. Its NADAC has been published 134 times since Mar 13, 2024.
FDA first approved this application on Mar 10, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
120 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862095730
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LURASIDONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208045FDA Approved
3/10/2023
TE Code
AB
On Market Since
3/10/2023
Pharmacological Classes
Price Statistics
The NADAC for LURASIDONE HCL 120 MG TABLET has been published 134 times since Mar 13, 2024, and over the history we have for it it has declined 27.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4867 per EA |
|---|---|
| All-time high | $0.8059 (Sep 11, 2024) |
| All-time low | $0.4824 (Aug 19, 2026) |
| 52-week high | $0.6838 |
| 52-week low | $0.4824 |
| Median price | $0.6246 |
| Average price | $0.6260 |
| Largest weekly change | +32.6% (Aug 21, 2024) |
| Weeks tracked | 134 |
| Tracking since | Mar 13, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the LURASIDONE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
LURASIDONE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LURASIDONE HCL 120 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LURASIDONE HCL 120 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.4867 per EA (NDC 65862095730), effective Sep 30, 2026.
How has the price of LURASIDONE HCL 120 MG TABLET changed over time?
Over the history we have for it, the NADAC for LURASIDONE HCL 120 MG TABLET has declined 27.8%. It has been tracked across 134 weekly CMS publications since Mar 13, 2024.
What are the highest and lowest recorded NADAC prices for LURASIDONE HCL 120 MG TABLET?
Since Mar 13, 2024, the NADAC for LURASIDONE HCL 120 MG TABLET has ranged from a low of $0.4824 (Aug 19, 2026) to a high of $0.8059 (Sep 11, 2024), with a median of $0.6246 per EA.
Are there cheaper alternatives to LURASIDONE HCL 120 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of LURASIDONE HCL 120 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LURASIDONE HCL 120 MG TABLET?
LURASIDONE HCL 120 MG TABLET (NDC 65862095730) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.